Overseas cash share of total cash of select US biopharma companies Q3 2017

This statistic shows the share of overseas cash out of total cash of select top U.S. pharmaceutical companies for the third quarterin 2017. In that period, Amgen Inc. held some 94 percent of its total cash outside the United States.

Share of overseas cash out of total cash of select U.S. pharmaceutical companies as of Q3 2017

Percentage of total cash
Amgen Inc94%
Bistrol-Myers Squibb Co90%
Pfizer Inc*90%
Abbvie Inc90%
Lily (Eli) & Co90%
Merck & Co**85%
Alexion Pharmaceuticals Inc81%
Gilead Sciences Inc78%
Celgene Corp77%
Biogen Inc67%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2017

Region

Worldwide

Survey time period

Q3 2017

Supplementary notes

* These companies have said that nearly all of their cash is overseas.
** The company has said that 80 to 90% of its cash is overseas.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biogen"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.